Cargando…
Examination of patient characteristics and hydroxychloroquine use based on the US Food and Drug Administration’s recommendation: a cross-sectional analysis in New York
OBJECTIVE: To describe the pattern of hydroxychloroquine use and examine the association between hydroxychloroquine use and clinical outcomes arising from changes in the US Food and Drug Administration (FDA)’s recommendation during the coronavirus disease 2019 (COVID-19) pandemic. DESIGN: A retrospe...
Autores principales: | Kim, Eun Ji, Coppa, Kevin, Hirsch, Jamie S, Abrahams, Sara, Johnson, Jennifer, Lesser, Martin, Davidson, Karina W, Conigliaro, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871686/ https://www.ncbi.nlm.nih.gov/pubmed/33558355 http://dx.doi.org/10.1136/bmjopen-2020-042965 |
Ejemplares similares
-
Retrospective analysis of dermatologic adverse events associated with hydroxychloroquine reported to the US Food and Drug Administration
por: Lipner, Shari R., et al.
Publicado: (2020) -
The U.S. Food and Drug Administration: Drug Information Resource for Formulary Recommendations
por: Marchand, Heidi C., et al.
Publicado: (2012) -
Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing
por: Harrigan, James J., et al.
Publicado: (2020) -
Examination of resident characteristics associated with interest in primary care and identification of barriers to cross-cultural care
por: Abrahams, Sara, et al.
Publicado: (2021) -
Guideline recommendations and antimicrobial resistance: the need for a change
por: Elias, Christelle, et al.
Publicado: (2017)